Directions:Please answer all the following questions and provide scholarly support.Your
responses should be written in APA format. Questions - Make a diagnosis (and
mention possible diagnoses/diagnoses to rule out) and explain the rationale for
the diagnosis. What are the points in favor of a bipolar II diagnosis? What
might account for the failure to respond to any of the prior treatments? Given
the diagnosis you have made, describe your medication treatment strategies.
Discuss not only initial choices of medications but also your next-step
strategy and why you’ve chosen it. (In doing so, be sure to provide a rationale
for your choices.) What questions should be addressed about the class of
medications that is chosen (e.g., mood
stabilizers)? Include a brief discussion of how you will integrate legal and
ethical considerations of diagnosis, treatment, and consultation with
medical professionals in light of the role and activities of the DEA. Readings:
Week 2 Readings: Handbook of Clinical Psychopharmacology for Therapists Ninth
Edition by John D. Preston PsyD ABPP (Author), John H. O'Neal MD (Author), Mary
C. Talaga RPh PhD (Author), Bret A. Moore PsyD ABPP (Author) Chapter 16:
Antidepressant Medications Chapter 17: Bipolar Medications Chapter 18:
Antianxiety Medications Chapter 19: Antipsychotic
Medications Readings in the DSM-5 - Depressive Disorders through Specifiers for
Depressive Disorders. Pp. 155-188. Bipolar and Related Disorders. pp.123-154 Anxiety
Disorders through Unspecified Obsessive-Compulsive and Related Disorder. pp.
189-264. Schizophrenia Spectrum and Other Psychotic Disorders through
Unspecified Schizophrenia Spectrum and Other Psychotic Disorder. pp. 87-122.
Articles- Sugarman, M. A. (2016). Are antidepressants and psychotherapy equally
effective in treating depression? A critical commentary. Journal of Mental
Health 25(6). 475-478. doi: 10.3109/09638237.2016.
Based on Eve’s clinical
presentation, which included a family history of psychiatric problems, recurrent
depressive episodes, and inadequate response to various antidepressants,
suggests bipolar spectrum type II disorder. This diagnosis is characterized by
cycles of hypomanic and depressive episodes (Haller et al., 2016). Although
Eve's depressive symptoms are prominent, the lack of response to multiple
antidepressants suggests an underlying bipolar component. It is crucial to
distinguish this from unipolar major depressive disorder due to the repetitive
nature of her depressive episodes. The initial episodes, triggered by
relationship issues, differ from subsequent occurrences that appear to arise
without identifiable psychosocial stressors. This precise diagnostic
distinction emphasizes the complexity of Eve's condition and underscores the
importance of a comprehensive evaluation (Sugarman, 2016). Thus, considering Bipolar II disorder as a
potential diagnosis informs treatment decisions, necessitating the use of mood
stabilizers instead of traditional antidepressants to address both depressive
and potential hypomanic states effectively.